ArticlePLOS global public health2025
Serial C-Reactive Protein Point-of-Care testing to optimize antibiotic treatment in hospitalized children with signs of infection in Zanzibar: A feasibility study.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Trial
- Drivers influencing antibiotics use in pediatric wards across five public hospitals in Zanzibar: a WHO multiple point prevalence survey.Frontiers in antibiotics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacterial infections are among the leading causes of morbidity and mortality in children, especially in low- and middle- income countries. As a result, antibiotics are frequently prescribed to children with signs of infection, even when cause may not be bacterial. This contributes to antimicrobial resistance (AMR), a global health concern. Integrating serial CRP point-of-care testing with culture and susceptibility testing may improve decision-making by facilitating earlier differentiation between bacterial and non-bacterial infections, promoting more appropriate antibiotic use.The study examined the feasibility of serial CRP POCT to guide discontinuation of antibiotic treatment in children in selected hospitals in Zanzibar, and to determine barriers to methods and procedures for the upcoming randomised controlled trial (RCT) (ISRCTN25937092).This prospective, individually randomized feasibility study was conducted between February 5 and March 3 2024 in two hospitals in Zanzibar. Research assistants and healthcare workers (HCWs) were trained on the use and interpretation of CRP POCT. Eligible neonates and children were randomized to CRP-guided or standard care antibiotic management. Feasibility was assessed using Bowen's framework; clinical outcomes were interpreted as exploratory.Eighty-two children participated, with a 96.0% follow-up rate. The CRP POCT intervention was rated "very important" by 89.7% of 58 HCWs. Adherence to CRP-based antibiotic guidance was high, though early discharges due to caregiver pressure were noted. The intervention integrated successfully into existing workflows and HCWs adapted the flowcharts in practice. Exploratory analysis showed CRP guidance reduced antibiotic treatment days in neonates with signs of infection (5.1 vs 6.6 days), and children aged 6 months to 12 years with febrile illness or diarrhoea (4.8 vs 6.7 days) compared to standard care, but the study was not powered for statistical inferences. This study suggests that the RCT of serial CRP POCT in guiding antibiotic treatment decision is feasible, and operationally implementable in this setting.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.